-
Rapamycin: Could a simple pill add years to your life?
03 May 2024 01:19 GMT
… Rapamune.
Here, it is authorised by the European Medicines … an inexpensive drug, now being off-patent.
“Pharmaceutical companies don’ … in rodents, including lower cancer incidence, improved cognitive, kidney … by the FDA. It’s used in oncology treatment, and …
-
Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting
30 Apr 2024 15:51 GMT
… in renal transplantation as Rapamune®(Pfizer). Through the … in Cancer and mTOR Inhibitors in Solid Tumor Targeting … contact: About Biodexa Pharmaceuticals PLC Biodexa Pharmaceuticals PLC (listed on … for the treatment of diseases with unmet medical needs. The …
-
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
26 Apr 2024 12:30 GMT
… Cancer Institute, part of the National Institutes of Health
Biodexa Pharmaceuticals … the treatment of diseases with unmet medical needs, … clinicians, investors and biotech executives that supported our … renal transplantation as Rapamune®(Pfizer). Through the …
-
Biodexa gains license for polyposis asset as stock more than doubles
29 Apr 2024 18:30 GMT
… marketed by Pfizer as Rapamune. As of 31 … drug won US Food and Drug Administration (FDA) approval in 2021 for the treatment … the parent company of Pharmaceutical Technology.
In the … II trial (NCT04375813) in non-muscle invasive bladder cancer (NMIBC …
-
The Role of Extracorporeal Photopheresis in the Management of Graft Versus Host Disease: Narrative Review
26 Apr 2024 13:07 GMT
… with immunosuppressive drugs. These medications are … Mofetil (CellCept®), Sirolimus (Rapamune®), Corticosteroids (methylprednisolone or … Food and Drug Administration (FDA) for cancer treatment. Its … System (Mallinckrodt Pharmaceuticals in New Jersey …
-
[Latest] Global 3D Cell Culture Market Size/Share Worth USD 4.6 Billion by 2033 at a 11.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
18 Apr 2024 16:30 GMT
… (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative medicine), By End User (Biotechnology and Pharmaceutical … Cancer, Lung Cancer, Prostate Cancer, Others), By End User (Hospitals, Specialty Clinics, Cancer Treatment Centers …
-
Anti-aging drug: Live longer thanks to rapamycin
28 Mar 2023 19:59 GMT
… approved as a drug under the trade name Rapamune – but only in … disturbances in fat metabolism and tumor formation.
It also seems that … could mean that short-term medication might be enough to get … do not succumb to the cancer as quickly. In addition to …
-
Human medicines European public assessment report (EPAR): Hyftor, sirolimus, Angiofibroma;Tuberous Sclerosis, Date of authorisation: 15/05/2023, Status: Authorised
21 Feb 2023 13:29 GMT
… a medicine used to treat benign (non-cancerous) skin tumours on … designated an ‘orphan medicine’ (a medicine used in rare diseases … similar to a ‘reference medicine’ containing the same active … way. While the reference medicine, Rapamune, is given by mouth …
-
Human medicines European public assessment report (EPAR): Hyftor, sirolimus, Angiofibroma;Tuberous Sclerosis, Date of authorisation: 15/05/2023, Status: Authorised
21 Feb 2023 13:29 GMT
… a medicine used to treat benign (non-cancerous) skin tumours on … designated an ‘orphan medicine’ (a medicine used in rare diseases … similar to a ‘reference medicine’ containing the same active … way. While the reference medicine, Rapamune, is given by mouth …
-
Rapamune dosage
29 Sep 2022 20:15 GMT
Rapamune (sirolimus) is a brand-name prescription medication. The Food and Drug Administration (FDA) has … dosage of Rapamune.
Before starting Rapamune treatment, tell your doctor about any other medical conditions …